
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 1088 | 1046 | 1083 | 1322 | 1926 |
Fund Return | 8.8% | 8.8% | 4.61% | 2.68% | 5.75% | 6.77% |
Place in category | 92 | 92 | 75 | 6 | 8 | 4 |
% in Category | 46 | 46 | 41 | 5 | 17 | 22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Blue Chip Selected Mixed | 37.5B | 8.60 | -3.66 | - | ||
E Fund CSI China Oversea Net 50 | 36.33B | 23.68 | 13.20 | - | ||
E Fund CSI300 ETF Feeder Fund | 20.48B | -0.94 | -0.35 | 1.97 | ||
E Fund SSE50 Index | 19.96B | -0.08 | -0.74 | 6.29 | ||
E Fund Consumer Sector | 19.68B | 0.61 | 0.06 | 10.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 2.37 | -15.41 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 2.17 | -16.08 | - | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 15.01 | 0.22 | - | ||
China Universal Healthcare Serv mix | 3.92B | 15.20 | -7.23 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 27.82 | 2.83 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.75 | 48.38 | -0.25% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 9.00 | 44.94 | +0.33% | |
New Industries | CNE100003T39 | 7.70 | 52.74 | -0.79% | |
APT Medical | CNE100004C45 | 6.89 | 431.48 | -0.35% | |
Eyebright Medical Technology Beijing | CNE1000041J5 | 5.46 | 104.56 | +0.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review